SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-322929
Filing Date
2013-08-07
Accepted
2013-08-07 07:30:52
Documents
13
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d558252d10q.htm 10-Q 510246
2 EX-10.1 d558252dex101.htm EX-10.1 23212
3 EX-10.2 d558252dex102.htm EX-10.2 13036
4 EX-31.1 d558252dex311.htm EX-31.1 6052
5 EX-31.2 d558252dex312.htm EX-31.2 6006
6 EX-32.1 d558252dex321.htm EX-32.1 3498
7 EX-32.2 d558252dex322.htm EX-32.2 3483
  Complete submission text file 0001193125-13-322929.txt   3917725

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT idix-20130630.xml EX-101.INS 327461
9 XBRL TAXONOMY EXTENSION SCHEMA idix-20130630.xsd EX-101.SCH 33498
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idix-20130630_cal.xml EX-101.CAL 40880
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idix-20130630_def.xml EX-101.DEF 156127
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE idix-20130630_lab.xml EX-101.LAB 235340
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idix-20130630_pre.xml EX-101.PRE 185257
Mailing Address 320 BENT STREET CAMBRIDGE MA 02141
Business Address 320 BENT STREET CAMBRIDGE MA 02141 617-995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-49839 | Film No.: 131015743
SIC: 2834 Pharmaceutical Preparations